Table 2. Breakdown of genotyped samples by Illumina SNP array type (columns 3—7), laboratory (column 8), and case/control/study status (rows).
370 | 610 | 1 M | 300 | 550 | Lab | ||
Centenarians | NECS | 583 | 102 | 176 | 0 | 0 | BU |
ELIXIR | 209 | 44 | 0 | 0 | 0 | BU | |
Controls | NECS | 237 | 4 | 0 | 0 | 0 | BU |
Illumina I | 0 | 0 | 0 | 89 | 584 | unknown | |
Illumina II | 0 | 0 | 0 | 62 | 279 | unknown | |
Illumina III | 0 | 0 | 0 | 574 | 2289 | unknown | |
Coriell NINDs | 867 | 0 | 0 | 0 | 0 | CIDR |
The columns of the table denote the Illumina array types. The column “Lab” denotes the laboratory that performed the genotyping: BU = Boston University; CIDR = Center for Inherited Disease Research. The row Illumina I denotes the control samples included in the discovery set; Illumina II denotes the control samples included in the first replication set, and Illumina III denotes the residual samples from the Illumina repository; Coriell NINDs denotes the neurologically normal controls.